| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.92 | 2e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |